Stockreport

Why Analysts Think Jazz Pharmaceuticals Story Is Changing After New Ziihera Growth Outlook [Yahoo! Finance]

Jazz Pharmaceuticals plc - Ordinary Shares  (JAZZ) 
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: jazzpharma.com
PDF Jazz Pharmaceuticals' fair value estimate has nudged up from $206.38 to $208.50 per share as analysts recalibrate their models around stronger long term growth prospects [Read more]